Product image of Methylphenidate Lp Eg (Methylphenidate Hydrochloride) supplied by GNH India

Methylphenidate Lp Eg

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Methylphenidate Lp Eg (Methylphenidate Hydrochloride)

Methylphenidate, the active ingredient in Methylphenidate Lp Eg, is a central nervous system stimulant presented as an oral tablet for oral use. It is available in a controlled‑release formulation designed to provide consistent plasma concentrations throughout the day and is prescribed to manage attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults.

GNH India supplies Methylphenidate Lp Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, meeting stringent quality standards and regulatory requirements.

Manufacturer / TM Owner

Eg Labo Laboratoires Eurogenerics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylphenidate acts on central nervous system pathways involved in attention and wakefulness, and is indicated for the following conditions:

  • Attention deficit hyperactivity disorder (ADHD): Improves concentration, reduces hyperactivity and impulsivity in patients of various ages.
  • Narcolepsy: Decreases excessive daytime sleepiness and improves wakefulness.

How It Works

  • Methylphenidate inhibits the reuptake of dopamine and norepinephrine by blocking their respective transporters (DAT and NET) in neuronal synapses. This increases the extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, executive function, and arousal, thereby improving focus and reducing sleepiness. The heightened catecholamine activity modulates activity in the prefrontal cortex and basal ganglia, supporting improved cognitive control and motor activity.

Side Effects

Methylphenidate may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Loss of appetite: reduced hunger leading to weight loss.
  • Headache: mild to moderate head pain.
  • Nausea: upset stomach or feeling sick.

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, hypertension, or arrhythmias.
  • Psychiatric symptoms: new or worsening anxiety, agitation, or hallucinations.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.

Precautions & Warnings

When prescribing Methylphenidate, clinicians should consider several safety measures and patient factors.

  • Cardiovascular assessment: evaluate blood pressure and heart rate before initiating therapy.
  • History of psychiatric disorders: monitor for emergence or worsening of anxiety, psychosis, or mood changes.
  • Potential for abuse: assess risk of dependence and misuse, especially in adolescents.
  • Drug interactions: review concomitant medications that affect catecholamine pathways.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Avoid Interactions

Methylphenidate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis; avoid concurrent use.
  • Tricyclic antidepressants: may increase cardiovascular side effects.
  • Antihypertensive agents: may reduce blood pressure control.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): may increase risk of serotonin syndrome.
  • Anticonvulsants (e.g., carbamazepine): may reduce methylphenidate plasma levels.
  • Proton pump inhibitors: may affect absorption.

Frequently Asked Questions

Methylphenidate Lp Eg is prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD it helps improve focus, reduce hyperactivity and impulsivity, while in narcolepsy it lessens excessive daytime sleepiness and supports wakefulness.

Methylphenidate blocks the reuptake of dopamine and norepinephrine in the brain, raising their levels in synaptic clefts. The increased catecholamine activity enhances signaling in regions that control attention, executive function, and arousal, leading to improved concentration and reduced sleepiness.

The appropriate dose of Methylphenidate Lp Eg is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and response to therapy. No fixed regimen is provided here; dosing decisions are made by the clinician.

The pregnancy category for methylphenidate is listed as unknown, and safety data are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylphenidate belongs to the central nervous system stimulant class and works by inhibiting dopamine and norepinephrine reuptake. Compared with amphetamine‑based stimulants, it has a slightly different pharmacologic profile and may be preferred when a patient experiences intolerance to amphetamines or requires a controlled‑release formulation.

Store Methylphenidate Lp Eg at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct light, and ensure the container is tightly closed to maintain product stability.

Methylphenidate Lp Eg is taken orally as a tablet. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional. Dosing times are usually scheduled to align with daily activities and to minimize sleep disturbances.

Serious risks include cardiovascular events such as hypertension, chest pain, or arrhythmias, as well as psychiatric effects like new or worsening anxiety, agitation, or hallucinations. Any sudden chest discomfort, severe headache, or behavioral changes should prompt immediate medical evaluation.

Methylphenidate Lp Eg is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors (MAOIs) within the past 14 days, and patients with severe cardiovascular disorders, uncontrolled hypertension, or a history of serious psychiatric conditions without appropriate supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT